Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
N-((4S,7S,10R,13S,16S,19S,22S,28S,31S,34R,37S,40S,43S,46R,49S,52S,55S)-52-((1H-indol-3-yl)methyl)-59-amino-31-(4-aminobutyl)-40-benzyl-13,28,37,49-tetra-sec-butyl-4-carbamoyl-16,43-diisobutyl-7,19-diisopropyl-10,34,46-tris(mercaptomethyl)-2,22-dimethyl-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54-heptadecaoxo-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53-heptadecaazanonapentacontan-55-yl)stearamide
ID: ALA4750714
PubChem CID: 162651127
Max Phase: Preclinical
Molecular Formula: C116H198N22O19S3
Molecular Weight: 2301.20
Molecule Type: Unknown
Associated Items: